Conference abstract · 21 Oct 2013
Conference abstractPublished 25 Sep 2017
Quality control in statistical programming under GCP
Cytel Statistical Software and Services Private Limited, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statistical programming to support clinical research and data analysis is vital in the drug discovery process. GCP is a prerequisite for any submission to regulatory authorities for drug approval and licensing. Quality control (QC) comes with different measures and tools following Standard Operating Procedures (SOPs), established by sponsor companies and/ or Contract Research Organizations (CROs). The SOPs are mainly based on GCP guidelines. This presentation exhibits brief overview of QC in overall clinical trials, with focus on QC done right for statistical programming in a R&D environment. It gives relevant definitions, processes followed, reasons for QC, challenges faced, deviations and expectations. The topic also describes roles, expertise, requirements, documentation and responsibilities involved. Given a drugâÂ?Â?s prospects, the impact of a solid QC process outweighs resource investments. Since quality is a key performance indicator and helps to select preferred partnership, pharmaceutical companies highly value CRO capabilities in conducting QC.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 14 Jul 2016
Considerations in upstream bioprocess monitoring and statistical data analysis in the context of process analytical technology and quality by design
Conference abstract · 10 Aug 2015
Creating high quality statistical graphs for publications
Article · 1 Mar 2022
Application of statistical toolsmixture optimal designs on optimization of glipizide controlled release tablets
Research article · 2022
Application of Statistical Tools-Mixture Optimal Designs on Optimization of Glipizide Controlled Release Tablets
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sharmeen Reza”

